A p-value approach to assessing In-vitro nonprofile bioequivalence
碩士 === 國立成功大學 === 統計學系碩博士班 === 90 === In 1999, the U.S. Food and Drug Administration(FDA)issue a graft guidance on Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action. For individual bioequivalence(IBE), the FDA provided a method of determining an upper 95...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | en_US |
Published: |
2002
|
Online Access: | http://ndltd.ncl.edu.tw/handle/69905591238992377387 |